| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
10,844 |
9,141 |
$59K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
266 |
258 |
$19K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
133 |
124 |
$4K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
84 |
79 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
286 |
278 |
$2K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
574 |
170 |
$1K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
169 |
169 |
$1K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,980 |
1,888 |
$899.65 |
| G0008 |
Administration of influenza virus vaccine |
411 |
411 |
$751.47 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
181 |
174 |
$600.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
27 |
25 |
$427.89 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
81 |
78 |
$410.64 |
| 20610 |
|
13 |
12 |
$294.12 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
169 |
169 |
$270.17 |
| Q3014 |
Telehealth originating site facility fee |
795 |
714 |
$254.69 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
153 |
147 |
$150.00 |
| 90662 |
|
164 |
164 |
$139.03 |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
24 |
24 |
$117.77 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
84 |
84 |
$34.10 |
| 36415 |
Collection of venous blood by venipuncture |
529 |
440 |
$23.94 |
| 90688 |
|
80 |
80 |
$22.78 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
32 |
27 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
81 |
70 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
25 |
24 |
$0.00 |
| 36416 |
|
14 |
14 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
13 |
13 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
22 |
22 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
12 |
12 |
$0.00 |